Pharma Reviews: China's Fosun to buy 74% stake in Gland Pharma for $1.1 bn in revised deal

Shanghai Fosun Pharmaceutical Group is trimming the size of the stake it will buy in India's Gland Pharma to 74 per cent for $1.1 billion, in a bid to ...
Read more: China's Fosun to buy 74% stake in Gland Pharma for $1.1 bn in revised deal